Lectrona logo Boehringer Ingelheim
Funding Opportunities for
Quality Improvement
Education (QIE) Grants

Quality Improvement Education (QIE) Grants

Boehringer Ingelheim is proud to support Quality Improvement Education grants examining educational methodologies and approaches that address clinical performance measures or quality indicators aligned to National Quality Priorities.

Specific QIE initiatives will focus on demonstrating improvement of patient care within health care organizations and will disseminate the impact of specific QIE initiatives via publications or real-world data reporting.

Types of QIE Initiatives
QIE initiatives include interventions designed independent of Boehringer Ingelheim’s input or involvement and may or may not include education that is certified for healthcare professionals. For those initiatives that do provide a form of certified education (CE), Boehringer Ingelheim cannot provide any resources or expertise into the development or execution of the educational interventions to ensure that the Independent Medical Education (IME) component remains free from Boehringer Ingelheim influence.

Boehringer Ingelheim also provides support for collaborative QIE opportunities where Boehringer Ingelheim may partner with an outside professional or medical association or society. Involvement may include dissemination of a Boehringer Ingelheim Request for Proposal to their members and/or assembling a final external review committee for funding decisions.

Cardiometabolism

Improve the quality of patient care by ensuring understanding of the clinical profiles of SGLT2 inhibitors and/or DPP4 inhibitors (or combinations), cardiovascular outcome trial results, and their clinical implications within current diabetes management, with emphasis on these areas:

1. Provider , Patient, and Care Partner Education
2. Treatment Guidelines / Recommendations
3. Coordination of Care

Biosimilars/CNS/Immunology

(Currently, proposals are not being accepted in this area at this time)

Cardiovascular

(Currently, proposals are not being accepted in this area at this time)

Oncology

(Currently, proposals are not being accepted in this area at this time)

Respiratory

(Currently, proposals are not being accepted in this area at this time)

Back to Medical Education Grant Overview

During the COVID-19 outbreak, patient, community and health care provider safety and wellbeing remains the highest priority for Boehringer Ingelheim Pharmaceuticals, Inc. ("BIPI").

The COVID-19 situation is changing on a daily basis across the world, which results in operational challenges; timelines and program-format modifications (i.e. live to virtual). It is our intent to be as flexible as reasonably possible with timelines as they pertain to start and end dates, program format, reports and other affected obligations, as stated in the agreement.

If a change of scope (COS) request is needed for an approved grant, please reach out to your BIPI Medical Education Personnel (MEP) to initiate the request within our Global Funding System.

For all payment, reconciliation, spend reporting questions or concerns; please reach out to our service mailbox at MEDSCICOMMOps.US@boehringer-ingelheim.com.

BIPI will evaluate every grant impacted on a case-by-case basis.

It is highly encouraged that any new grant submissions with a start date prior to September 1, 2020, only include virtual or print components.

Any grants after the start date of September 1, 2020, can include live activities.

We wish you, your staff and your family good health.